Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254

Proteomics
Caroline VipondJun X Wheeler

Abstract

In the absence of a suitable carbohydrate-based vaccine, outer membrane vesicle (OMV) vaccines have been used to disrupt outbreaks of serogroup B meningococcal disease for more than 20 years. Proteomic technology provides physical methods with the potential to assess the composition and consistency of these complex vaccines. 2-DE, combined with MS, were used to generate a proteome map of an OMV vaccine, developed to disrupt a long-running outbreak of group B disease in New Zealand. Seventy four spots from the protein map were identified including the outer membrane protein (OMP) antigens: PorA, PorB, RmpM and OpcA. Protein identification indicates that, in addition to OMPs, OMV vaccines contain periplasmic, membrane-associated and cytoplasmic proteins. 2-D-DIGE technology highlighted differences between preclinical development batches of vaccines from two different manufacturers.

References

May 6, 1976·Nature·G R Jacobson, J P Rosenbusch
Jan 1, 1983·Reviews of Infectious Diseases·H Peltola
Apr 7, 1997·The Journal of Experimental Medicine·D MartinB R Brodeur
May 7, 1998·Molecular Microbiology·F P de VriesJ P van Putten
Mar 6, 1999·Microbiology and Molecular Biology Reviews : MMBR·W W Navarre, O Schneewind
May 12, 2000·European Journal of Biochemistry·M P MolloyA A Gooley
May 3, 2001·The New England Journal of Medicine·N E RosensteinJ M Hughes
Aug 10, 2001·JAMA : the Journal of the American Medical Association·M G BruceM Collins
Apr 16, 2002·Infection and Immunity·Paul A CullenBen Adler
Sep 25, 2002·Molecular Biology and Evolution·Rachel UrwinMartin C J Maiden
May 7, 2003·Current Opinion in Microbiology·Elizabeth A CraigHeather A Hundley
Jun 5, 2003·Trends in Microbiology·Christine M SzymanskiBrendan W Wren
Jul 2, 2003·Proteomics·Enrica PessioneCarlo Giunta

❮ Previous
Next ❯

Citations

Aug 8, 2007·Analytical and Bioanalytical Chemistry·Ralf J BraunMarius Ueffing
Apr 17, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Alexandra Schubert-Unkmeir, Myron Christodoulides
Feb 16, 2013·Journal of Proteome Research·Bas van de WaterbeemdAd P J M de Jong
Feb 11, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dan M Granoff
Mar 4, 2010·Microbiology and Molecular Biology Reviews : MMBR·Terri N Ellis, Meta J Kuehn
Jun 17, 2009·PloS One·Tom A MendumJohnjoe McFadden
Nov 19, 2010·Bioanalysis·Neil RavenscroftChristopher Jones
Nov 23, 2011·Biomarkers in Medicine·Ruoli ChenJun X Wheeler
Aug 7, 2007·Expert Review of Anti-infective Therapy·Rolando PajónRay Borrow
Sep 17, 2011·Expert Review of Vaccines·Donatella PanattoRoberto Gasparini
Jun 6, 2009·Expert Review of Proteomics·Elzbieta Katarzyna Jagusztyn-KrynickaPaula Roszczenko
Dec 22, 2012·Expert Review of Vaccines·Holly SandersGermie Pjm van den Dobbelsteen
Oct 19, 2007·Expert Review of Proteomics·Giulia BernardiniAnnalisa Santucci
Feb 1, 2007·Proteomics. Clinical Applications·Jun X WheelerYuan Zhao
Sep 10, 2008·Proteomics·Richard J SimpsonJustin W E Lim
Apr 19, 2008·Mass Spectrometry Reviews·Eun-Young LeeYong Song Gho
Jul 14, 2007·Proteomics·Giulia BernardiniAnnalisa Santucci
Sep 1, 2007·Proteomics. Clinical Applications·Jun X WheelerIan M Feavers
Jan 15, 2009·Journal of Medical Microbiology·Gretel SardiñasOlivia Niebla
May 27, 2016·Molecular BioSystems·Anita HorvatićMangesh Bhide
Jan 1, 2015·Emerging Microbes & Infections·Sebastian E CarrascoX Frank Yang
May 20, 2018·Journal of Applied Microbiology·K ShahinA Adams
May 13, 2009·Molecular Microbiology·Brooke L DeatherageBrad T Cookson
May 3, 2019·Scientific Reports·Amaka M AwanyeJeremy P Derrick
Jul 16, 2014·Expert Review of Proteomics·Myron Christodoulides
Jul 15, 2015·Proteomics. Clinical Applications·Allison C Galassie, Andrew J Link

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.